Bora Pharmaceuticals Co., LTD. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 706.00
-1.00 (-0.14%)
Sep 12, 2025, 1:30 PM CST
TPE:6472 Market Cap
TPE:6472 has a market cap or net worth of 87.62 billion as of September 12, 2025. Its market cap has increased by 17.36% in one year.
Market Cap
87.62B
Enterprise Value
103.08B
Revenue
21.32B
Ranking
n/a
PE Ratio
18.55
Stock Price
706.00
Market Cap Chart
Since October 3, 2014, TPE:6472's market cap has increased from 3.16B to 87.62B, an increase of 2,671.06%. That is a compound annual growth rate of 35.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 87.62B | 12.75% |
| Dec 31, 2024 | 77.71B | 20.27% |
| Dec 29, 2023 | 64.61B | 107.61% |
| Dec 30, 2022 | 31.12B | 150.04% |
| Dec 30, 2021 | 12.45B | 17.05% |
| Dec 31, 2020 | 10.63B | 89.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 321.06B |
| PharmaEssentia | 186.40B |
| Lotus Pharmaceutical | 49.18B |
| Lumosa Therapeutics | 48.10B |
| Oneness Biotech | 34.10B |
| Polaris Group | 29.12B |
| Center Laboratories | 27.28B |
| Pell Bio-Med Technology | 25.70B |